caffeine has been researched along with oxidopamine in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (19.15) | 18.7374 |
| 1990's | 8 (17.02) | 18.2507 |
| 2000's | 19 (40.43) | 29.6817 |
| 2010's | 10 (21.28) | 24.3611 |
| 2020's | 1 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Finn, IB; Holtzman, SG; Iuvone, PM | 1 |
| Carey, RJ | 1 |
| French, ED | 1 |
| Erinoff, L; Snodgrass, SR | 1 |
| Branch, RA; Holycross, B; Jackson, EK; Li, P; Ohnishi, A | 1 |
| Koley, BN; Koley, J; Saha, JK | 1 |
| Casas, M; Herrera-Marschitz, M; Ungerstedt, U | 1 |
| French, ED; Vantini, G | 1 |
| Basura, M; Erinoff, L; Kelly, PH; Snodgrass, SR | 1 |
| Joyce, EM; Koob, GF | 1 |
| Schiffmann, SN; Vanderhaeghen, JJ | 1 |
| Reid, A; Sawynok, J | 1 |
| Ferré, S; Fuxe, K; Giménez-Llort, L; Martínez, E; Pezzola, A; Popoli, P; Reggio, R | 1 |
| Fenu, S; Morelli, M | 1 |
| Barbanoj, M; Casas, M; Jané, F; Kulisevsky, J; Prat, G; Robledo, P | 3 |
| Barbanoj, M; Casas, M; Jané, F; Prat, G; Rubio, A | 1 |
| Barbanoj, M; Casas, M; Jané, F; Prat, G; Robledo, P; Rubio, A | 1 |
| Dassesse, D; Ledent, C; Meunier, JC; Parmentier, M; Schiffmann, SN | 1 |
| Cauli, O; Morelli, M; Pinna, A; Valentini, V | 1 |
| Amalric, M; Breysse, N; Coccurello, R | 1 |
| Casas, M; Núñez-Taltavull, JF; Prat, G; Robledo, P; Rubio, A | 1 |
| Cauli, O; Morelli, M | 1 |
| Bové, J; Cortés, R; Marin, C; Mengod, G; Serrats, J; Tolosa, E | 1 |
| Friedman, MI; Stricker, EM; Zigmond, MJ; Zimmerman, MB | 1 |
| Chen, JF; Schwarzschild, MA; Yu, L | 1 |
| Cauli, O; Morelli, M; Pinna, A | 1 |
| Aguilar, E; Bové, J; Cortés, R; Marin, C; Mengod, G; Serrats, J | 1 |
| Aguiar, LM; Cunha, GM; Freitas, RM; Macêdo, DS; Nobre, HV; Oliveira, AA; Sousa, FC; Vasconcelos, SM; Viana, GS | 1 |
| Morelli, M; Pinna, A; Simola, N; Tronci, E | 1 |
| Barbanoj, M; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V | 1 |
| Aguiar, LM; de Sousa, FC; Macêdo, DS; Oliveira, AA; Vasconcelos, SM; Viana, GS | 1 |
| Kelsey, JE; Langelier, NA; Oriel, BS; Reedy, C | 1 |
| Ba, M; Kong, M; Liu, Z; Ma, Y; Song, L | 1 |
| Chen, JF; Herm, L; Kalda, A; Rinken, A; Zharkovsky, A | 1 |
| Cunha, GM; de Moraes, MO; de Vasconcelos, LM; Leal, LK; Magalhães, HI; Maia, FD; Nobre, HV; Oliveira Neto, RN; Viana, GS | 1 |
| Dimitrov, KD; Drake, JD; Pollack, AE | 1 |
| Burdett, TC; Cassin, JJ; Chen, JF; Fredholm, BB; Healy, B; Schwarzschild, MA; Xiao, D | 1 |
| Ahern, S; Caballero, M; Carbonell, L; Ciruela, F; Cuffí, ML; Fernández-Dueñas, V; Núñez, F; Sánchez, S | 1 |
| Dziubina, A; Gołembiowska, K | 1 |
| Acuña-Lizama, MM; Alvarez-Cervera, FJ; Bata-García, JL; Góngora-Alfaro, JL | 1 |
| Cavalheiro, EA; Cerqueira, GS; Correia, AO; de Barros Viana, GS; de Castro Brito, GA; Machado-Filho, JA; Montenegro, AB; Naffah-Mazzacoratti, Mda G; Neves, KR; Nobre, ME | 1 |
| Mahmoudi, J; Reyhani-Rad, S | 1 |
| Haining, RL; Hernandez, A; Jones, TM | 1 |
| Abuhamdah, SM; Abuirmeileh, AN; Alzoubi, KH; Ashraf, A | 1 |
1 review(s) available for caffeine and oxidopamine
| Article | Year |
|---|---|
Caffeine and the dopaminergic system.
Topics: Adrenergic Agents; Animals; Behavior; Caffeine; Central Nervous System Stimulants; Drug Interactions; Humans; Motor Activity; Oxidopamine; Rats; Receptor, Adenosine A2A; Receptors, Dopamine; Reinforcement, Psychology | 2005 |
46 other study(ies) available for caffeine and oxidopamine
| Article | Year |
|---|---|
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
Topics: alpha-Methyltyrosine; Animals; Brain Chemistry; Caffeine; Catecholamines; Dextroamphetamine; Diencephalon; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Male; Methylphenidate; Methyltyrosines; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reserpine; Telencephalon; Tyrosine 3-Monooxygenase | 1990 |
Antiparkinsonian effects of caffeine depend upon pavlovian drug conditioning processes.
Topics: Animals; Apomorphine; Caffeine; Conditioning, Classical; Functional Laterality; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Rotation; Substantia Nigra | 1990 |
Effects of N-allylnormetazocine (SKF 10,047), phencyclidine, and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area.
Topics: Amphetamine; Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Phenazocine; Phencyclidine; Rats; Rats, Inbred Strains; Scopolamine; Tegmentum Mesencephali | 1986 |
Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Topics: 5,7-Dihydroxytryptamine; Age Factors; Animals; Animals, Newborn; Biogenic Amines; Brain Chemistry; Caffeine; Dihydroxytryptamines; Drug Interactions; Hydroxydopamines; Motor Activity; Norepinephrine; Oxidopamine; Rats; Serotonin | 1986 |
Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system.
Topics: Angiotensin II; Animals; Blood Pressure; Caffeine; Drug Interactions; Hydroxydopamines; Male; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Sympathectomy, Chemical; Sympathetic Nervous System | 1987 |
Effects of nicotine on spontaneous contractions of isolated atria of toad (Bufo melanostictus).
Topics: Animals; Atropine; Bufonidae; Caffeine; Edetic Acid; Hemicholinium 3; Hexamethonium Compounds; Hydroxydopamines; In Vitro Techniques; Myocardial Contraction; Nicotine; Oxidopamine; Physostigmine; Tyramine; Verapamil | 1987 |
Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses.
Topics: Animals; Apomorphine; Caffeine; Corpus Striatum; Denervation; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Injections, Intraventricular; Kainic Acid; Male; Oxidopamine; Rats; Rats, Inbred Strains; Rotation; Stereotyped Behavior; Substantia Nigra | 1988 |
Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Hydroxydopamines; Motor Activity; Nucleus Accumbens; Oxidopamine; Phenazocine; Phencyclidine; Rats; Receptors, Dopamine; Scopolamine; Septal Nuclei | 1984 |
Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.
Topics: Aging; alpha-Methyltyrosine; Animals; Body Weight; Brain; Brain Chemistry; Caffeine; Catecholamines; Choline O-Acetyltransferase; Enzymes; Female; Glutamate Decarboxylase; Hydroxydopamines; Male; Methyltyrosines; Motor Activity; Oxidopamine; Pimozide; Pregnancy; Rats; Sex Characteristics | 1984 |
Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
Topics: Animals; Apomorphine; Caffeine; Dextroamphetamine; Hydroxydopamines; Locomotion; Male; Nucleus Accumbens; Oxidopamine; Rats; Receptors, Dopamine; Scopolamine; Septal Nuclei | 1981 |
Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Corpus Striatum; Enkephalins; Gene Expression Regulation; Globus Pallidus; Neurons; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Purinergic; Substance P; Substantia Nigra | 1993 |
Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Analgesia; Animals; Brain; Caffeine; Central Nervous System Stimulants; Dopamine; Formaldehyde; Male; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Serotonin | 1996 |
Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Locomotion; Male; Mice; Mice, Inbred Strains; Motor Activity; Motor Neurons; Oxidopamine; Purinergic P1 Receptor Antagonists; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sympatholytics; Theophylline | 1996 |
Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors.
Topics: Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Male; Motor Activity; Oxidopamine; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stimulation, Chemical; Triazoles; Xanthines | 1998 |
Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Tolerance; Functional Laterality; Male; Muscarinic Antagonists; N-Methylscopolamine; Nerve Degeneration; Oxidopamine; Parasympatholytics; Rats; Rats, Sprague-Dawley; Scopolamine; Sodium Chloride; Stereotyped Behavior | 1999 |
Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Drug Therapy, Combination; Drug Tolerance; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Rats | 1999 |
Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Caffeine; Dopamine Agonists; Drug Synergism; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation | 2000 |
Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats.
Topics: Animals; Bromocriptine; Caffeine; Denervation; Drug Administration Schedule; Drug Combinations; Drug Tolerance; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Sprague-Dawley; Rotation | 2000 |
Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Caffeine; Corpus Striatum; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Drinking; Eating; Male; Neural Pathways; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sulpiride; Syndrome; Theophylline; Xanthines | 2000 |
Regulation of nociceptin mRNA expression in the septum by dopamine and adenosine systems.
Topics: Adenosine; Animals; Caffeine; Denervation; Dopamine; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Neural Pathways; Neurons; Nociceptin; Opioid Peptides; Oxidopamine; Receptor, Adenosine A2A; Receptors, Dopamine; Receptors, Purinergic P1; RNA, Messenger; Septal Nuclei; Stress, Physiological | 2000 |
Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.
Topics: Amphetamine; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine; Drug Administration Schedule; Drug Interactions; Functional Laterality; Male; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Stimulation, Chemical; Sympatholytics; Time Factors | 2003 |
Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Caffeine; Conditioning, Operant; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Gene Expression Regulation; Genes, fos; Male; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Phosphoproteins; Phosphorylation; Psychomotor Performance; Pyridines; Rats; Reaction Time; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Sympatholytics | 2004 |
Biphasic effects of oxotremorine-M on turning behavior induced by caffeine in 6-OHDA-lesioned rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Caffeine; Dose-Response Relationship, Drug; Male; Muscarinic Agonists; Oxidopamine; Oxotremorine; Rats; Rats, Sprague-Dawley | 2004 |
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.
Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Cell Count; Dynorphins; Enkephalins; Globus Pallidus; Immunohistochemistry; In Situ Hybridization; Male; Microinjections; Neostriatum; Neural Pathways; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; RNA, Messenger; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2005 |
Caffeine restores feeding response to 2-deoxy-D-glucose in 6-hydroxydopamine-treated rats.
Topics: Animals; Blood Glucose; Body Weight; Caffeine; Deoxyglucose; Eating; Feeding Behavior; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Theophylline; Xanthenes | 1977 |
Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Time Factors | 2006 |
Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Caffeine; Central Nervous System Stimulants; Dopamine Agents; Dopamine Agonists; Levodopa; Male; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics | 2005 |
Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine; Adrenergic Agents; Animals; Caffeine; Corpus Striatum; Dynorphins; Dyskinesias; Enkephalins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger | 2006 |
Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.
Topics: Animals; Apomorphine; Brain; Brain Diseases; Caffeine; Disease Models, Animal; Dopamine Agents; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar | 2006 |
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Male; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympatholytics | 2006 |
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Benzylamines; Brain; Caffeine; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2007 |
CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
Topics: Adenosine A2 Receptor Agonists; Animals; Behavior, Animal; Biogenic Monoamines; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Lipid Peroxidation; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Neuroprotective Agents; Nitrites; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Receptors, Adenosine A2; Rotation; Serotonin | 2008 |
The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Caffeine; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Globus Pallidus; Injections; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Long-Evans | 2009 |
Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats.
Topics: Adenosine A2 Receptor Agonists; Animals; Antiparkinson Agents; Caffeine; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; Levodopa; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Motor Activity; Movement; Oxidopamine; Parkinson Disease, Secondary; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Signal Transduction; Up-Regulation | 2009 |
Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Benzazepines; Caffeine; Corpus Striatum; Dopamine Agonists; Drug Therapy, Combination; Guanosine 5'-O-(3-Thiotriphosphate); Levodopa; Lisuride; Male; Mice; Mice, Inbred C57BL; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Random Allocation; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulfur Radioisotopes | 2009 |
Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
Topics: Adenosine A2 Receptor Agonists; Animals; Apoptosis; Caffeine; Cells, Cultured; Encephalitis; Female; Free Radicals; Inflammation Mediators; Lipid Peroxidation; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitrites; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Receptor, Adenosine A2A; Substantia Nigra; Sympatholytics; Xanthines | 2010 |
Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Functional Laterality; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sympathectomy, Chemical; Sympatholytics; Time Factors | 2010 |
Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Caffeine; Corpus Striatum; Disease Models, Animal; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Gene Expression Regulation; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidopamine; Parkinson Disease; Protein Precursors; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Messenger; Statistics, Nonparametric; Time Factors | 2011 |
Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Motor Activity; Oxidopamine; Rats | 2011 |
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Benserazide; Caffeine; Dopamine; Glutamic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles | 2012 |
Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats.
Topics: Animals; Caffeine; Catalepsy; Corpus Striatum; Dopaminergic Neurons; Dose-Response Relationship, Drug; Haloperidol; Male; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Theophylline | 2013 |
Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Apomorphine; Brain; Caffeine; Cytokines; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Exploratory Behavior; Histone Deacetylases; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2014 |
Effect of adenosine A2A receptor antagonists on motor disorders induced by 6-hydroxydopamine in rat.
Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Disease Models, Animal; Hypokinesia; Male; Motor Activity; Motor Disorders; Oxidopamine; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Rats, Wistar; Time and Motion Studies | 2016 |
Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.
Topics: Caffeine; Cysteine; Dopamine; Iron; Melanins; Nicotine; Oxidopamine; Parkinson Disease; Polymerization; Spectrometry, Fluorescence | 2016 |
Protective effect of caffeine and/or taurine on the 6-hydroxydopamine-induced rat model of Parkinson's disease: Behavioral and neurochemical evidence.
Topics: Animals; Apomorphine; Behavior, Animal; Caffeine; Corpus Striatum; Disease Models, Animal; Dopamine; Oxidopamine; Parkinson Disease; Rats; Taurine | 2021 |